Expression and regulation of interleukin-1 receptors in the brain.: Role in cytokines-induced sickness behavior

被引:115
作者
Parnet, P
Kelley, KW
Bluthé, RM
Dantzer, R
机构
[1] Inst Francois Magendie, INRA, Lab Integrat Neurobiol, INSERM,U394, F-33077 Bordeaux, France
[2] Univ Illinois, Dept Anim Sci, Immunophysiol Lab, Edward R Madigan Lab 207, Urbana, IL 61801 USA
关键词
interleukin-1; receptor; brain; sickness behavior;
D O I
10.1016/S0165-5728(02)00022-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sickness behavior refers to the coordinated set of behavior changes that develop in sick individuals during the course of an infection. At the molecular level, these changes are due to the effects of proinflammatory cytokines as interleukin-1 on the brain. The purpose of this article is not to review the entire field of cytokines and behavior, but rather to address the role of interleukin-1 receptors (IL-1Rs,) in sickness behavior. We briefly describe the notion of sickness behavior and present the distribution of IL-1Rs in the central nervous system of the human, mouse and rat. We then bring arguments in favor of the functionality of the various subtypes of receptors and evaluate the nature of the signaling pathways activated by brain IL-1Rs to initiate central modifications leading to symptoms of sickness. Finally, modulation of IL-1 action on its receptor by various opposing factors including glucocorticoids and anti-inflammatory cytokines is discussed. (C) 2002 Elsevier Science B.V All rights reserved.
引用
收藏
页码:5 / 14
页数:10
相关论文
共 75 条
[1]   Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages [J].
Akashi, S ;
Shimazu, R ;
Ogata, H ;
Nagai, Y ;
Takeda, K ;
Kimoto, M ;
Miyake, K .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3471-3475
[2]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[3]  
BACUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141
[4]   I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR [J].
BAEUERLE, PA ;
BALTIMORE, D .
SCIENCE, 1988, 242 (4878) :540-546
[5]   BRAIN INTERLEUKIN-1 GENE-EXPRESSION INDUCED BY PERIPHERAL LIPOPOLYSACCHARIDE ADMINISTRATION [J].
BAN, E ;
HAOUR, F ;
LENSTRA, R .
CYTOKINE, 1992, 4 (01) :48-54
[6]   RECEPTORS FOR INTERLEUKIN-1 (ALPHA AND BETA) IN MOUSE-BRAIN - MAPPING AND NEURONAL LOCALIZATION IN HIPPOCAMPUS [J].
BAN, E ;
MILON, G ;
PRUDHOMME, N ;
FILLION, G ;
HAOUR, F .
NEUROSCIENCE, 1991, 43 (01) :21-30
[7]   THE I-KAPPA-B PROTEINS - MULTIFUNCTIONAL REGULATORS OF REL/NF-KAPPA-B TRANSCRIPTION FACTORS [J].
BEG, AA ;
BALDWIN, AS .
GENES & DEVELOPMENT, 1993, 7 (11) :2064-2070
[8]   ALTERNATIVE PROMOTER USAGE OF THE FOS-RESPONSIVE GENE FIT-1 GENERATES MESSENGER-RNA ISOFORMS CODING FOR EITHER SECRETED OR MEMBRANE-BOUND PROTEINS RELATED TO THE IL-1 RECEPTOR [J].
BERGERS, G ;
REIKERSTORFER, A ;
BRASELMANN, S ;
GRANINGER, P ;
BUSSLINGER, M .
EMBO JOURNAL, 1994, 13 (05) :1176-1188
[9]   Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats [J].
Bluthé, RM ;
Castanon, N ;
Pousset, F ;
Bristow, A ;
Ball, C ;
Lestage, J ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
PSYCHONEUROENDOCRINOLOGY, 1999, 24 (03) :301-311
[10]   Role of interleukin-1β and tumour necrosis factor-α in lipopolysaccharide-induced sickness behaviour:: a study with interleukin-1 type I receptor-deficient mice [J].
Bluthé, RM ;
Layé, S ;
Michaud, B ;
Combe, C ;
Dantzer, R ;
Parnet, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (12) :4447-4456